3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
16
Carcinoma, Renal Cell
14
Neoplasm Metastasis
8
Carcinoma, Non-Small-Cell Lung
7
Carcinoma, Hepatocellular
7
Neoplasms
6
Carcinoma, Medullary
6
Thyroid Neoplasms
5
Melanoma
5
Breast Neoplasms
5
Ovarian Neoplasms
4
Neuroendocrine Tumors
4
Carcinoma, Transitional Cell
4
Brain Neoplasms
4
Thyroid Cancer, Papillary
3
Small Cell Lung Carcinoma
3
Sarcoma
3
Pancreatic Neoplasms
3
Lung Neoplasms
3
Kidney Neoplasms
3
Adenocarcinoma, Follicular
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Sarcoma, Ewing
2
Recurrence
2
Pheochromocytoma
2
Paraganglioma
2
Pain
2
Osteosarcoma
2
Multiple Myeloma
2
Interventions
pembrolizumab
3
Axitinib
2
regorafenib
1
avelumab
1
amivantamab
1
Tretinoin
1
Specimen Handling
1
Radiation
1
Pemetrexed
1
Nelfinavir
1
Magnetic Resonance Spectroscopy
1
Glutamate Carboxypeptidase II
1
GSK-3326595
1
Etoposide
1
Endoscopic Mucosal Resection
1
Doxorubicin
1
Cisplatin
1
Bortezomib
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Adenoid Cystic
×
cabozantinib
×
Clear all
No trials found.